1. Home
  2. KALA vs HSON Comparison

KALA vs HSON Comparison

Compare KALA & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • HSON
  • Stock Information
  • Founded
  • KALA 2009
  • HSON 1999
  • Country
  • KALA United States
  • HSON United States
  • Employees
  • KALA N/A
  • HSON N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • HSON Professional Services
  • Sector
  • KALA Health Care
  • HSON Consumer Discretionary
  • Exchange
  • KALA Nasdaq
  • HSON Nasdaq
  • Market Cap
  • KALA 26.2M
  • HSON 26.1M
  • IPO Year
  • KALA 2017
  • HSON N/A
  • Fundamental
  • Price
  • KALA $5.86
  • HSON $8.72
  • Analyst Decision
  • KALA Strong Buy
  • HSON
  • Analyst Count
  • KALA 3
  • HSON 0
  • Target Price
  • KALA $14.00
  • HSON N/A
  • AVG Volume (30 Days)
  • KALA 123.2K
  • HSON 14.9K
  • Earning Date
  • KALA 08-05-2025
  • HSON 08-07-2025
  • Dividend Yield
  • KALA N/A
  • HSON N/A
  • EPS Growth
  • KALA N/A
  • HSON N/A
  • EPS
  • KALA N/A
  • HSON N/A
  • Revenue
  • KALA N/A
  • HSON $138,031,000.00
  • Revenue This Year
  • KALA N/A
  • HSON $0.80
  • Revenue Next Year
  • KALA N/A
  • HSON $8.09
  • P/E Ratio
  • KALA N/A
  • HSON N/A
  • Revenue Growth
  • KALA N/A
  • HSON N/A
  • 52 Week Low
  • KALA $2.92
  • HSON $8.28
  • 52 Week High
  • KALA $11.20
  • HSON $18.99
  • Technical
  • Relative Strength Index (RSI)
  • KALA 60.68
  • HSON 42.64
  • Support Level
  • KALA $4.36
  • HSON $8.35
  • Resistance Level
  • KALA $7.00
  • HSON $8.80
  • Average True Range (ATR)
  • KALA 0.71
  • HSON 0.33
  • MACD
  • KALA 0.16
  • HSON 0.05
  • Stochastic Oscillator
  • KALA 63.97
  • HSON 27.69

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: